Related Experiment Video
Updated: Feb 8, 2026
09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
4.0K
Prophylactic antibiotics in pediatric neurological surgery
Friederike Knerlich-Lukoschus1, Martina Messing-Jünger2
1Department of Pediatric Neurosurgery, Asklepios Klinik Sankt Augustin GmbH, Arnold-Janssen-Str. 29, 53757, Sankt Augustin, Germany. f.knerlich@asklepios.com.
Summary
Surgical antibiotic prophylaxis (SAP) in pediatric neurosurgery lacks characterization. More multi-center studies are needed to establish evidence-based guidelines for preventing surgical site infections (SSIs) in this population.
Area of Science:
- Neurosurgery
- Infectious Disease Prevention
- Pediatric Medicine
Background:
- Surgical antibiotic prophylaxis (SAP) is crucial for preventing surgical site infections (SSIs).
- Current understanding of SAP in pediatric neurosurgery is limited.
- Standardized approaches for antimicrobial use in pediatric neurosurgical procedures are lacking.
Purpose of the Study:
- To review the current literature on SAP in pediatric neurosurgery.
- To extract existing recommendations and guidelines for SAP in this specific patient group.
- To identify gaps in evidence regarding SAP for pediatric neurosurgical procedures.
Main Methods:
- Comprehensive literature review focusing on SAP in pediatric neurosurgery.
- Analysis of available recommendations from online databases.
- Separate consideration of clean neurosurgical, shunt, and implant surgeries.
Main Results:
- Evidence-based data on SAP in pediatric neurosurgery is sparse.
- There are no standardized protocols for adequate antimicrobial use for SSI prevention in pediatric neurosurgery.
- Current practices are not well-defined for this vulnerable population.
Conclusions:
- Multi-center surveillance studies are essential for developing robust SAP recommendations.
- Further research is required to implement evidence-based SAP guidelines in pediatric neurosurgery.
- Standardization of SAP is critical for improving patient outcomes and reducing SSIs.
Related Concept Videos
00:57Antibiotic Selection
60.0K
Overview
60.0K
01:30Development of Antibiotic Resistance
1.5K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
266
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
320
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
239
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
305
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305